Volume 34 Number 12 March 26 - April 2, 2015
Cancer
A retrospective study of the impact of 21-gene recurrence score assay on treatment choice in node positive micrometastatic breast cancer.
Frazier TG et al. Pharmaceuticals (Basel) 2015 8(1) 107-22
Frazier TG et al. Pharmaceuticals (Basel) 2015 8(1) 107-22
Breast Cancer Risk After Salpingo-Oophorectomy in Healthy BRCA1/2 Mutation Carriers: Revisiting the Evidence for Risk Reduction.
Heemskerk-Gerritsen BA et al. J. Natl. Cancer Inst. 2015 May 107(5)
Heemskerk-Gerritsen BA et al. J. Natl. Cancer Inst. 2015 May 107(5)
Cancer risks in Jewish male BRCA1 and BRCA2 mutation carriers.
Laitman Y et al. Breast Cancer Res. Treat. 2015 Mar 19.
Laitman Y et al. Breast Cancer Res. Treat. 2015 Mar 19.
Comparative effectiveness of screening strategies for Lynch syndrome.
Barzi A et al. J. Natl. Cancer Inst. 2015 Apr 107(4)
Barzi A et al. J. Natl. Cancer Inst. 2015 Apr 107(4)
Effects of genetic and environmental risk assessment feedback on colorectal cancer screening adherence.
Myers RE et al. J Behav Med 2015 Mar 18.
Myers RE et al. J Behav Med 2015 Mar 18.
Family matters in Lynch syndrome.
Kastrinos F et al. J. Natl. Cancer Inst. 2015 Apr 107(4)
Kastrinos F et al. J. Natl. Cancer Inst. 2015 Apr 107(4)
Genotype-phenotype correlations by ethnicity and mutation location in BRCA mutation carriers.
Bayraktar S et al. Breast J 2015 Mar 19.
Bayraktar S et al. Breast J 2015 Mar 19.
Identification of a candidate gene panel for the early diagnosis of prostate cancer.
Leyten GH et al. Clin. Cancer Res. 2015 Mar 18.
Leyten GH et al. Clin. Cancer Res. 2015 Mar 18.
In the era of genomics, should tumor size be reconsidered as a criterion for neoadjuvant chemotherapy?
Pivot X et al. Oncologist 2015 Mar 20.
Pivot X et al. Oncologist 2015 Mar 20.
miR-test: A blood test for lung cancer early detection.
Montani F et al. J. Natl. Cancer Inst. 2015 Jun 107(6)
Montani F et al. J. Natl. Cancer Inst. 2015 Jun 107(6)
Personalized assessment and management of women at risk for breast cancer in North America.
Pruthi S et al. Womens Health (Lond Engl) 2015 Mar 11(2) 213-24
Pruthi S et al. Womens Health (Lond Engl) 2015 Mar 11(2) 213-24
Personalized oncogenomics: clinical experience with malignant peritoneal mesothelioma using whole genome sequencing.
Sheffield BS et al. PLoS ONE 2015 10(3) e0119689
Sheffield BS et al. PLoS ONE 2015 10(3) e0119689
Psychosocial Impact of Lynch Syndrome on Affected Individuals and Families.
Galiatsatos P et al. Dig. Dis. Sci. 2015 Mar 19.
Galiatsatos P et al. Dig. Dis. Sci. 2015 Mar 19.
Risk-reducing surgery in hereditary gynecological cancer: Clinical applications in Lynch syndrome and hereditary breast and ovarian cancer.
Adachi M, et al. Mol Clin Oncol. 2015 Mar;3(2):267-273.
Adachi M, et al. Mol Clin Oncol. 2015 Mar;3(2):267-273.
Validation of an online questionnaire for identifying people at risk of familial and hereditary colorectal cancer.
Kallenberg FG, et al. Fam Cancer. 2015 Mar 24.
Kallenberg FG, et al. Fam Cancer. 2015 Mar 24.
No hay comentarios:
Publicar un comentario